Ependymoma - Childhood

Surgical Resection of Ependymoma in the 4th Ventricle
Surgical Resection of Ependymoma in the 4th Ventricle administrator 5 Views • 2 years ago

Ependymoma Surgery in the 4th ventricle requires microsurgical and endoscopic techniques for safe and maximal tumor resection.

In this video, Dr. Daniel Kelly, Director of the Pacific Brain Tumor Center, Providence Saint John's Health Center demonstrates the surgical removal of an ependymoma within the 4th ventricle using microsurgical techniques and endoscopic visualization.

Ependymomas are glial neoplasms (gliomas) that can arise in any of the brain's fluid-filled chambers (cerebral ventricles). When they arise in the 4th ventricle, they can cause headaches, slurred speech, swallowing difficulties, coordination and balance difficulties as well as hydrocephalus. In this case, the patient was a young man who developed progressive and severe headaches leading to an MRI and the diagnosis of a 4th ventricular tumor. The MRI clearly showed the tumor causing pressure on the brainstem and cerebellum. The surgical video demonstrates how the tumor was approached through a suboccipital craniotomy, the route into the 4th ventricle, microscopic tumor removal and finally the use of endoscopy to confirm maximal tumor resection. Fortunately in our patient, over 97% of the tumor was able to be removed and it was low grade ependymomas (WHO Grade II). Given the small remaining tumor remnant left adherent to the brainstem, he was treated with stereotactic radiation shortly after surgery. Now more than 5 years after surgery, he is doing well with no evidence of tumor regrowth.

At the Pacific Brain Tumor Center we have one of the world's largest experiences treating all types of brain and skull base tumors using minimally invasive keyhole and endoscopic approaches.

https://pacificneuro.org
https://pacificneuro.org/kelly
https//pacificbraintumor.org | 310-582-7450

PARVEZ MASOOD | BRAIN TUMORS PART IV | INTRA VENTRICULAR TUMOUR | EPENDYMOMA
PARVEZ MASOOD | BRAIN TUMORS PART IV | INTRA VENTRICULAR TUMOUR | EPENDYMOMA administrator 0 Views • 2 years ago

We are IndianRadiologist - www.indianradiologist.com
Follow us on Social Media for Event info, New videos, Free Classifieds Information on Jobs & Machines, Unusual & Rare Radiology Images, New Product Reviews & More
YOUTUBE: Subscribe & Click on the Bell Icon for notifications: https://www.youtube.com/indian....radiologist?sub_conf
FACEBOOK: https://www.facebook.com/groups/indianradiologist/
YOUTUBE: www.youtube.com/indianradiologist
INSTAGRAM: https://www.instagram/Indianradiologist

#braintumor #mribraintumour #ependymoma

In this video, learn about: ependymoma, subependymoma, hydrocephalus, mass effect, choroid plexus tumors.
Quick learning videos on Radiology for UG and Residents in Radiology. Subscribe to Indian Radiologist and get free Radiology teaching videos from experts in the field of Radiology.

Ependymoma
Ependymoma administrator 0 Views • 2 years ago

D.Kovac, Neurora counsellor
Sina Falahati, MD, neurosurgical reviewer
Ependymomas are a rare type of gilal Tumors. They constitute 10 % of the Tumors occuring in the central nervous System. Males and females are equaly affected, especially children around five years of age, but also adults.
The ventricular system is a set of four interconnected cavities (ventricles) in the brain, where the cerebrospinal fluid celled CSF) is produced. Within each ventricle is a region of choroid plexus, a network of ependymal cells involved in the production of CSF. The ventricular system is continuous with the central canal of the spinal cord (from the fourth ventricle) allowing for the flow of CSF to circulate.
Risk factors are not clearly known. Neurofibromatosis type II has been associated with increased incidence with spinal chord ependymomas.
Most ependymomas are slow growing Tumors of children and Young adults, but there are also faster growing more malignant types. In the WHO classification of brain tumours ependymomas are divided into four Major subtypes - Myxopapillary ependymoma, subependymoma - both grade I, classic ependymoma - grade II and anaplastic ependymoma - grade III.
Depending on the Tumors location - posterior fossa lesions - lead to headache, Nausea, vomiting, Balance Problems called ataxia, dizziness and other Symptoms related to increased intracranial pressure. Sometimes seizurs or neurological deficits like muscle weakness are among the first Symptoms. Ependymomas within the spinal chord will usually Show Symptoms of muscle weakness, sensoric deficit and ataxia - all depending on the Tumors location and size.
All These Symptoms are not specific and can be related to many causes, many of them harmless.
Dissemination of the Tumor through the cerebrospinal fluid is not common, but is observed.
Radiologic Imaging - MRI and CT Scans can reveal the underlying cause of the Symptoms.
Usually MRI scan of the entire neuraxis - brain and spinal chord should be done to exclude metastases.
In most cases the initial Treatment of ependymomas should consist of maximal safe resection.
Chemotherapy Plays some roles in younger children or in some patients with bulk residual disease.
Incompletely resected ependymomas of grade II and grade III may require a short period of chemo-therapy and a second-look surgery.
Much in disease is still under research. It is recommended to visit specialized centers for the therapy of ependymomas.

PNOC Ependymoma Informational Webinar May 21, 2021
PNOC Ependymoma Informational Webinar May 21, 2021 administrator 3 Views • 2 years ago

The Pacific Pediatric Neuro-Oncology Consortium (PNOC) is an international consortium, led by Dr. Sabine Mueller and Dr. Michael Prados, with centers within the United States, Europe, Asia and Australia. PNOC are dedicated to bringing new therapies to children and young adults with brain tumors. PNOC's goal is to improve outcomes by translating the latest findings in brain tumor biology into better treatments for these children.

As part of our ongoing webinar series on May 21st we presented the PNOC Ependymoma webinar to provide updates on research and clinical trials and to answer patient family questions.

FEATURED SPEAKERS:

Dr. Mariella Filbin Co-Director for Research, Pediatric Neuro-oncology Program, Assistant Professor of Pediatrics, Harvard Medical School; Associate Member, Broad Institute of Harvard and MIT, Dana-Farber/Boston Children's Cancer and Blood Disorder Center

Dr. Eugene (Gene) Hwang Pediatric Neuro-Oncologist, PNOC Ependymoma Research Group; Associate Division Chief, Oncology, Children's National Hospital

Dr. Torunn Yock Director, Pediatric Radiation Oncology, MGH; Professor, Harvard Medical School; Chair, Quality Improvement Committee, Francis H. Burr Proton Therapy Center

and

Dr. Sabine Mueller PNOC Co-Founder and Project Leader, Professor of Clinical Neurology, UCSF

Dr. Cassie Kline Attending Physician, Director, Neuro-Oncology Clinical Research; Kortney Rose Foundation Clinical Researcher in Neuro-Oncology; Children’s Hospital of Philadelphia; PNOC Director of Data Quality and Integration

Thank you to Lindsay for sharing her story today and all the patient families who tuned in live and asked questions.

For more information on PNOC and PNOC's Ependymoma Research Group please visit
https://pnoc.us

If you would like to learn more about PNOC Foundation or support Ependymoma research please visit https://www.pnocfoundation.org

PNOC is not only a collaboration of doctors, scientists and patient families, it also represents a collaboration of funders and advocates. We gratefully acknowledge the support of PNOC's Ependymoma work and this webinar by following collaborations foundations: Dragon Master Foundation, Tommy Strong Foundation, National Brain Tumor Society, Robert Dawes Foundation and CERN Foundation.

Showing 24 out of 25